Assessment of blinding in clinical trials
Controlled Clinical Trials · 2004-04 · 25 (2) · 143-156
DOI: 10.1016/j.cct.2003.10.016 ↗Kurz gefasst
Fachartikel in der Zeitschrift Controlled Clinical Trials, 2004-04. Verfasst von Heejung Bang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biostatistics, University of North Carolina at Chapel Hill, 137 E. Franklin Street, Chapel Hill, NC 27599, USA. hejung_bang@unc.edu. Hauptthemen laut MEDLINE: Double-Blind Method. Die Arbeit wurde bisher 611-mal zitiert (Crossref) und nennt 17 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Biostatistics, University of North Carolina at Chapel Hill, 137 E. Franklin Street, Chapel Hill, NC 27599, USA. hejung_bang@unc.edu
Zitieren
APA
Bang, H., Ni, L., & Davis, C. E. (2004). Assessment of blinding in clinical trials. Controlled Clinical Trials, 25(2), 143-156. https://doi.org/10.1016/j.cct.2003.10.016
Vancouver
Bang H, Ni L, Davis CE. Assessment of blinding in clinical trials. Controlled Clinical Trials. 2004;25(2):143-156. doi:10.1016/j.cct.2003.10.016
BibTeX
@article{Bang2004,
author = {Bang, Heejung and Ni, Liyun and Davis, Clarence E},
title = {Assessment of blinding in clinical trials},
journal = {Controlled Clinical Trials},
year = {2004},
volume = {25},
number = {2},
pages = {143--156},
doi = {10.1016/j.cct.2003.10.016}
}
EUVIMED